Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Urinary cadmium and mammographic density in premenopausal women.

Adams SV, Newcomb PA, Shafer MM, Atkinson C, Bowles EJ, Newton KM, Lampe JW.

Breast Cancer Res Treat. 2011 Aug;128(3):837-44. doi: 10.1007/s10549-011-1383-8.

2.

Sources of cadmium exposure among healthy premenopausal women.

Adams SV, Newcomb PA, Shafer MM, Atkinson C, Bowles EJ, Newton KM, Lampe JW.

Sci Total Environ. 2011 Apr 1;409(9):1632-7. doi: 10.1016/j.scitotenv.2011.01.037.

3.

Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density.

Diorio C, Pollak M, Byrne C, Mâsse B, Hébert-Croteau N, Yaffe M, Coté G, Bérubé S, Morin C, Brisson J.

Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1065-73.

4.

Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk.

Kerlikowske K, Ichikawa L, Miglioretti DL, Buist DS, Vacek PM, Smith-Bindman R, Yankaskas B, Carney PA, Ballard-Barbash R; National Institutes of Health Breast Cancer Surveillance Consortium..

J Natl Cancer Inst. 2007 Mar 7;99(5):386-95.

5.

Fertility drug use and mammographic breast density in a mammography screening cohort of premenopausal women.

Sprague BL, Trentham-Dietz A, Terry MB, Nichols HB, Bersch AJ, Buist DS.

Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3128-33. doi: 10.1158/1055-9965.EPI-08-0503.

6.

The relationship between bone mineral density and mammographic density in Korean women: the Healthy Twin study.

Sung J, Song YM, Stone J, Lee K.

Breast Cancer Res Treat. 2011 Sep;129(2):583-91. doi: 10.1007/s10549-011-1523-1.

PMID:
21512766
7.

Are breast density and bone mineral density independent risk factors for breast cancer?

Kerlikowske K, Shepherd J, Creasman J, Tice JA, Ziv E, Cummings SR.

J Natl Cancer Inst. 2005 Mar 2;97(5):368-74.

8.

Modified effect of urinary cadmium on breast cancer risk by selenium.

Wei XL, He JR, Cen YL, Su Y, Chen LJ, Lin Y, Wu BH, Su FX, Tang LY, Ren ZF.

Clin Chim Acta. 2015 Jan 1;438:80-5. doi: 10.1016/j.cca.2014.08.014.

PMID:
25149105
9.

Mammographic density and estrogen receptor status of breast cancer.

Ziv E, Tice J, Smith-Bindman R, Shepherd J, Cummings S, Kerlikowske K.

Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2090-5.

10.

The influence of mammogram acquisition on the mammographic density and breast cancer association in the Mayo Mammography Health Study cohort.

Olson JE, Sellers TA, Scott CG, Schueler BA, Brandt KR, Serie DJ, Jensen MR, Wu FF, Morton MJ, Heine JJ, Couch FJ, Pankratz VS, Vachon CM.

Breast Cancer Res. 2012 Nov 15;14(6):R147. doi: 10.1186/bcr3357.

11.

Cadmium exposure and the risk of breast cancer in Japanese women.

Nagata C, Nagao Y, Nakamura K, Wada K, Tamai Y, Tsuji M, Yamamoto S, Kashiki Y.

Breast Cancer Res Treat. 2013 Feb;138(1):235-9. doi: 10.1007/s10549-013-2414-4.

PMID:
23358902
12.

The relation of urinary estrogen metabolites with mammographic densities in premenopausal women.

Maskarinec G, Heak S, Morimoto Y, Custer L, Franke AA.

Cancer Epidemiol. 2012 Oct;36(5):e310-6. doi: 10.1016/j.canep.2012.03.014.

13.

Premenopausal plasma 25-hydroxyvitamin D, mammographic density, and risk of breast cancer.

Bertrand KA, Rosner B, Eliassen AH, Hankinson SE, Rexrode KM, Willett W, Tamimi RM.

Breast Cancer Res Treat. 2015 Jan;149(2):479-87. doi: 10.1007/s10549-014-3247-5.

14.

Polymorphisms in genes involved in the estrogen pathway and mammographic density.

Dumas I, Diorio C.

BMC Cancer. 2010 Nov 22;10:636. doi: 10.1186/1471-2407-10-636.

15.

Urinary estrogens and estrogen metabolites and mammographic density in premenopausal women.

Bertrand KA, Eliassen AH, Hankinson SE, Gierach GL, Xu X, Rosner B, Ziegler RG, Tamimi RM.

Breast Cancer Res Treat. 2012 Nov;136(1):277-87. doi: 10.1007/s10549-012-2240-0.

16.

Reported mammographic density: film-screen versus digital acquisition.

Harvey JA, Gard CC, Miglioretti DL, Yankaskas BC, Kerlikowske K, Buist DS, Geller BA, Onega TL; Breast Cancer Surveillance Consortium..

Radiology. 2013 Mar;266(3):752-8. doi: 10.1148/radiol.12120221.

17.

Prognostic significance of mammographic density change after initiation of tamoxifen for ER-positive breast cancer.

Nyante SJ, Sherman ME, Pfeiffer RM, Berrington de Gonzalez A, Brinton LA, Aiello Bowles EJ, Hoover RN, Glass A, Gierach GL.

J Natl Cancer Inst. 2015 Feb 6;107(3). pii: dju425. doi: 10.1093/jnci/dju425.

18.

Associations between mammographic density and body composition in Hispanic and non-Hispanic white women by menopause status.

Caire-Juvera G, Arendell LA, Maskarinec G, Thomson CA, Chen Z.

Menopause. 2008 Mar-Apr;15(2):319-25.

PMID:
18090034
19.

Nondense mammographic area and risk of breast cancer.

Pettersson A, Hankinson SE, Willett WC, Lagiou P, Trichopoulos D, Tamimi RM.

Breast Cancer Res. 2011 Oct 21;13(5):R100. doi: 10.1186/bcr3041.

20.

Accuracy of assigned BI-RADS breast density category definitions.

Nicholson BT, LoRusso AP, Smolkin M, Bovbjerg VE, Petroni GR, Harvey JA.

Acad Radiol. 2006 Sep;13(9):1143-9.

PMID:
16935726
Items per page

Supplemental Content

Support Center